Glenmede Trust CO Na Incyte Corp Transaction History
Glenmede Trust CO Na
- $18.2 Billion
- Q1 2025
A detailed history of Glenmede Trust CO Na transactions in Incyte Corp stock. As of the latest transaction made, Glenmede Trust CO Na holds 629,926 shares of INCY stock, worth $54.9 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
629,926
Previous 636,970
1.11%
Holding current value
$54.9 Million
Previous $44 Million
13.3%
% of portfolio
0.21%
Previous 0.23%
Shares
15 transactions
Others Institutions Holding INCY
# of Institutions
730Shares Held
202MCall Options Held
516KPut Options Held
265K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.68 Billion21.22% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.86 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.1MShares$1.76 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.6MShares$1.27 Billion0.6% of portfolio
-
State Street Corp Boston, MA9.88MShares$861 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $19.4B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...